Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study | PLOS ONE
![PHARMACOLOGY DRUG LIST 14 MOD 200 A. JAMES. Immunomodulators AVONEX AVONEX Interferon beta 1a Interferon beta 1a COPAXONE COPAXONE glatiramer glatiramer. - ppt download PHARMACOLOGY DRUG LIST 14 MOD 200 A. JAMES. Immunomodulators AVONEX AVONEX Interferon beta 1a Interferon beta 1a COPAXONE COPAXONE glatiramer glatiramer. - ppt download](https://images.slideplayer.com/19/5785182/slides/slide_4.jpg)
PHARMACOLOGY DRUG LIST 14 MOD 200 A. JAMES. Immunomodulators AVONEX AVONEX Interferon beta 1a Interferon beta 1a COPAXONE COPAXONE glatiramer glatiramer. - ppt download
![PHARMACOLOGY DRUG LIST 14 MOD 200 A. JAMES. Immunomodulators AVONEX AVONEX Interferon beta 1a Interferon beta 1a COPAXONE COPAXONE glatiramer glatiramer. - ppt download PHARMACOLOGY DRUG LIST 14 MOD 200 A. JAMES. Immunomodulators AVONEX AVONEX Interferon beta 1a Interferon beta 1a COPAXONE COPAXONE glatiramer glatiramer. - ppt download](https://images.slideplayer.com/19/5785182/slides/slide_3.jpg)
PHARMACOLOGY DRUG LIST 14 MOD 200 A. JAMES. Immunomodulators AVONEX AVONEX Interferon beta 1a Interferon beta 1a COPAXONE COPAXONE glatiramer glatiramer. - ppt download
![What You Need to Know About Interferon Beta (Avonex®, Betaseron®, Extavia®, Rebif®) (video) | National Multiple Sclerosis Society What You Need to Know About Interferon Beta (Avonex®, Betaseron®, Extavia®, Rebif®) (video) | National Multiple Sclerosis Society](https://i.ytimg.com/vi/yVBKi1VliBI/maxresdefault.jpg)
What You Need to Know About Interferon Beta (Avonex®, Betaseron®, Extavia®, Rebif®) (video) | National Multiple Sclerosis Society
Adverse Events of Interferon Beta-1a: A Prospective Multi-Centre International ICH-GCP-Based CRO-Supported External Validation Study in Daily Practice | PLOS ONE
![Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis | NEJM Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2000/nejm_2000.343.issue-13/nejm200009283431301/production/images/img_medium/nejm200009283431301_f1.jpeg)